Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer

被引:0
|
作者
Pignot, G. [1 ]
机构
[1] Univ Paris Sud, Hop Bicetre, Serv Urol, F-94270 Le Kremlin Bicetre, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 10期
关键词
Non-muscle invasive bladder cancer; Cystoscopy; Diagnosis; Recurrence; Cost-effectiveness; Indications; GUIDED FLUORESCENCE CYSTOSCOPY; CARCINOMA IN-SITU; PHOTODYNAMIC DIAGNOSIS; COST-EFFECTIVENESS; FOLLOW-UP; COST/BENEFIT/THERAPEUTIC VALUE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; MUSCLE; RECURRENCE;
D O I
10.1016/j.purol.2015.05.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Blue-light cystoscopy aims to facilitate the detection of bladder tumors in order to optimize the completeness of resection. We performed a literature analysis using data from Medline and according to PRISMA guidelines. Several meta-analyses have confirmed the interest of the blue-light cystoscopy in terms of improved detection rate and disease-free survival compared to standard white-light cystoscopy. These benefits outweigh the initial costs related to the acquisition of specific equipment, allowing an improvement in quality-adjusted life-years and a reduction of costs over time. Indications vary according to guidelines and must take into account equipment and logistic constraints on each center. The objective of this article is to make a focus on the role and the interest of blue-light cystoscopy in the management of NMIBC in 2015. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 50 条
  • [41] Non-muscle-invasive bladder cancer: a vision for the future
    Malmstrom, Per-Uno
    Agrawal, Sachin
    Blackberg, Mats
    Bostrom, Peter J.
    Malavaud, Bernard
    Zaak, Dirk
    Hermann, Gregers G.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (02) : 87 - 94
  • [42] Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review
    Parrao, Diego
    Lizana, Nemecio
    Saavedra, Catalina
    Larranaga, Matias
    Lindsay, Carolina B.
    San Francisco, Ignacio F.
    Bravo, Juan Cristobal
    CURRENT ONCOLOGY, 2024, 31 (04) : 2201 - 2220
  • [43] Rational follow-up of non-muscle invasive bladder cancer
    von Landenberg, N.
    Benderska-Soeder, N.
    Bismarck, E.
    Kernig, K.
    Erne, E.
    Goebell, P. J.
    Schmitz-Draeger, B. J.
    UROLOGE, 2021, 60 (11): : 1409 - 1415
  • [44] Non-muscle invasive bladder cancer. Current aspects of diagnostics, local therapy options and the update of the 2016 WHO classification
    Karl, A.
    Grimm, T.
    Jokisch, F.
    Gaisa, N. T.
    Stief, C. G.
    UROLOGE, 2016, 55 (09): : 1247 - 1256
  • [45] The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer
    Clinton, Timothy N.
    Lotan, Yair
    FUTURE ONCOLOGY, 2018, 14 (27) : 2805 - 2810
  • [46] Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry
    Ahmadi, Hamed
    Ladi-Seyedian, Seyedeh Sanam
    Konety, Badrinath
    Pohar, Kamal
    Holzbeierlein, Jeffrey M.
    Kates, Max
    Willard, Brian
    Taylor, Jennifer M.
    Liao, Joseph C.
    Kaimakliotis, Hristos Z.
    Porten, Sima P.
    Steinberg, Gary D.
    Tyson, Mark D.
    Lotan, Yair
    Daneshmand, Siamak
    BJU INTERNATIONAL, 2022, 130 (01) : 62 - 67
  • [47] Therapeutic Outcome of Fluorescence Cystoscopy Guided Transurethral Resection in Patients with Non-Muscle Invasive Bladder Cancer: A Meta-Analysis of Randomized Controlled Trials
    Yuan, Haichao
    Qiu, Jianguo
    Liu, Liangren
    Zheng, Shuo
    Yang, Lu
    Liu, Zhenghua
    Pu, Chunxiao
    Li, Jinhong
    Wei, Qiang
    Han, Ping
    PLOS ONE, 2013, 8 (09):
  • [48] Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden
    Dansk, Viktor
    Malmstrom, Per-Uno
    Blackberg, Mats
    Malmenas, Maria
    FUTURE ONCOLOGY, 2016, 12 (08) : 1025 - 1038
  • [49] Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
    Audenet, Francois
    Retinger, Caitlyn
    Chien, Christine
    Benfante, Nicole E.
    Bochner, Bernard H.
    Donat, S. Machele
    Herr, Harry W.
    Dalbagni, Guido
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 603.e1 - 603.e5
  • [50] The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer
    Naselli, Angelo
    Hurle, Rodolfo
    Puppo, Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (12) : 1523 - 1528